Petco Health and Wellness
WOOF
2.20
-0.03
-1.13%
Petco Health and Wellness
US · WOOF
#3589 by market cap
Listed 2021
2.20
-0.03
-1.13%
Live - 5344 symbols - heartbeat 279s ago
· 2026-10-08 09:57
Pre-market
2.18
-1.80%
After-hours
2.21
-0.36%
Overnight
2.22
0.00%
- Market cap
- 628.69M
- P/E (TTM)i
- 21.95
- P/Bi
- 0.52
- EPSi
- 0.03
- Div yieldi
- 0.00%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on WOOF?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.99, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.53% YoY
Margins
- Gross margin
- 38.67%
- Operating margin
- 2.02%
- Net margin
- 0.15%
Key ratios & quality
- Enterprise valuei
- 2.19B
- Altman Z-Scorei
- 0.99
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.39B | 4.43B | 4.92B | 5.81B | 6.04B | 6.26B | 6.12B | 5.96B |
| Gross profit | 1.90B | 1.91B | 2.11B | 2.43B | 2.43B | 2.35B | 2.32B | 2.31B |
| Selling & admin expenses | 1.75B | 1.78B | 1.91B | 2.16B | 2.20B | 2.31B | 2.32B | 2.18B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 158.45M | 129.60M | 194.42M | 266.07M | 225.56M | 42.21M | 7.05M | 120.43M |
| Pretax profit | -458.50M | -142.08M | -41.56M | 202.40M | 112.28M | -1.32B | -127.97M | -5.03M |
| Tax | -45.84M | -35.66M | -3.34M | 53.47M | 35.35M | -27.61M | -7.48M | 6.27M |
| Net profit | -413.79M | -103.98M | -31.74M | 159.81M | 89.91M | -1.28B | -101.82M | 9.07M |
| Basic EPS | -1 | 0 | 0 | 1 | 0 | -5 | 0 | 0 |
| Diluted EPS | -1.40 | -0.33 | -0.13 | 0.62 | 0.34 | -4.78 | -0.37 | 0.03 |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 1.49B | 1.49B | 1.46B | 1.52B | 1.50B | 1.49B |
| Gross profit | 569.97M | 585.32M | 569.02M | 580.77M | 574.43M | 591.15M |
| Selling & admin expenses | 553.61M | 542.30M | 539.82M | 548.91M | 549.80M | 543.34M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 16.36M | 43.02M | 29.20M | 31.86M | 24.63M | 47.81M |
| Pretax profit | -15.78M | 10.63M | -1.82M | 1.93M | -18.50M | 17.75M |
| Tax | 495.00K | 746.00K | -6.28M | 11.30M | 2.20M | -15.71M |
| Net profit | -11.66M | 13.97M | 9.33M | -2.58M | -15.15M | 38.66M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.04 | 0.05 | 0.03 | -0.01 | -0.05 | 0.13 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 761.61M | 711.01M | 777.55M | 1.07B | 1.02B | 951.74M | 973.62M | 1.02B |
| Cash & ST investments | 180.65M | 148.79M | 111.40M | 211.60M | 201.90M | 125.43M | 165.76M | 256.74M |
| Inventory | 470.14M | 478.97M | 538.68M | 675.11M | 652.43M | 684.50M | 653.33M | 590.21M |
| Total assets | 4.92B | 6.16B | 6.08B | 6.50B | 6.61B | 5.36B | 5.19B | 5.17B |
| Total current liabilities | 543.47M | 841.94M | 875.31M | 1.05B | 1.02B | 1.11B | 1.14B | 1.13B |
| Short-term debt | 28.35M | 306.87M | 260.49M | 287.66M | 332.56M | 326.47M | 311.75M | 324.69M |
| Long-term debt | 3.20B | 3.23B | 1.65B | 1.64B | 1.63B | 1.58B | 1.58B | 1.49B |
| Total liabilities | 4,286,470,000.00 | 5,594,057,000.00 | 4,020,437,000.00 | 4,242,122,000.00 | 4,231,352,000.00 | 4,178,723,000.00 | 4,080,800,000.00 | 4,009,171,000.00 |
| Total equity | 637.91M | 561.06M | 2.06B | 2.26B | 2.38B | 1.18B | 1.11B | 1.16B |
| Retained earnings | -707.52M | -780.47M | -22.25M | 142.17M | 232.97M | -1.05B | -1.15B | -1.14B |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 920.43M | 939.56M | 1.01B | 1.02B | 960.84M | 1.05B |
| Cash & ST investments | 133.34M | 188.75M | 237.41M | 256.74M | 166.80M | 293.50M |
| Inventory | 645.47M | 608.51M | 617.90M | 590.21M | 632.91M | 601.59M |
| Total assets | 5.12B | 5.15B | 5.21B | 5.17B | 5.08B | 5.17B |
| Total current liabilities | 1.08B | 1.06B | 1.10B | 1.13B | 1.13B | 1.17B |
| Short-term debt | 310.42M | 312.36M | 351.75M | 324.69M | 325.64M | 352.70M |
| Long-term debt | 1.58B | 1.58B | 1.58B | 1.49B | 1.46B | 1.46B |
| Total liabilities | 4,013,806,000.00 | 4,014,179,000.00 | 4,047,528,000.00 | 4,009,171,000.00 | 3,929,281,000.00 | 3,959,723,000.00 |
| Total equity | 1.11B | 1.14B | 1.16B | 1.16B | 1.16B | 1.21B |
| Retained earnings | -1.16B | -1.15B | -1.14B | -1.14B | -1.16B | -1.12B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 203.20M | 110.34M | 268.62M | 358.22M | 346.00M | 215.72M | 177.67M | 314.05M |
| Depreciation & amortization | 187.00M | 173.54M | 174.84M | 172.43M | 193.83M | 203.62M | 208.52M | 196.71M |
| Free cash flow | 54.84M | -47.02M | 109.06M | 119.11M | 67.98M | -9.88M | 49.68M | 186.95M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -111.00K | 0 | 935.94M | -- | 0 | 0 | 2.50M | 0 |
| Ending cash balance | 186.49M | 154.72M | 119.54M | 221.89M | 213.73M | 136.65M | 181.67M | 269.41M |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | -15.45M | 85.89M | 90.09M | 153.52M | -30.97M | 161.55M |
| Depreciation & amortization | 49.81M | 49.36M | 49.30M | 48.24M | 49.04M | 50.40M |
| Free cash flow | -43.87M | 53.79M | 60.65M | 116.39M | -69.12M | 129.92M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 138.74M | 189.73M | 249.42M | 269.41M | 167.96M | 294.50M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -64.87 | -15.88 | -2.01 | 7.57 | 3.90 | -71.80 | -8.86 | 0.80 |
| ROA %i | -8.40 | -1.73 | -0.43 | 2.62 | 1.39 | -21.38 | -1.93 | 0.17 |
| ROIC %i | -5.04 | 2.05 | 3.25 | 4.29 | 3.01 | -23.36 | 0.69 | 2.08 |
| 5-year avg ROE %i | -- | -- | -- | -- | -14.26 | -15.64 | -14.24 | -13.68 |
| EBIT margin %i | -4.89 | 2.50 | 3.61 | 4.82 | 3.54 | -18.75 | 0.25 | 2.12 |
| FCF / sales %i | 1.25 | -- | 2.22 | 2.05 | 1.13 | -- | 0.81 | 3.14 |
| Current ratioi | 1.40 | 0.84 | 0.89 | 1.02 | 0.99 | 0.86 | 0.85 | 0.90 |
| Quick ratioi | 0.38 | 0.21 | 0.18 | 0.25 | 0.25 | 0.15 | 0.18 | 0.27 |
| Debt / assetsi | 65.51 | 76.23 | 49.41 | 46.93 | 47.37 | 56.45 | 56.51 | 55.39 |
| LT debt / equityi | 501.23 | 770.15 | 132.50 | 121.44 | 117.58 | 228.05 | 235.60 | 218.23 |
| Interest coveragei | -0.88 | 0.44 | 0.81 | 3.62 | 2.10 | -7.77 | 0.11 | 0.96 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 9.76 | 10.82 | 8.33 | 1.74 | -0.41 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -53.61 |
| FCF CAGR (3Y) %i | -- | -- | -- | 29.50 | -- | -- | -25.28 | 40.10 |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -5.90 | -2.48 | -0.19 | 0.80 | 0.49 | 2.58 |
| ROA %i | -1.29 | -0.54 | -0.04 | 0.17 | 0.11 | 0.59 |
| ROIC %i | 1.58 | 1.70 | 2.73 | 2.08 | 2.01 | 2.55 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 0.86 | 1.54 | 1.84 | 2.12 | 2.06 | 2.16 |
| FCF / sales %i | 0.77 | 0.97 | 2.16 | 3.14 | 2.71 | 3.99 |
| Current ratioi | 0.85 | 0.89 | 0.91 | 0.90 | 0.85 | 0.90 |
| Quick ratioi | 0.16 | 0.21 | 0.25 | 0.27 | 0.18 | 0.28 |
| Debt / assetsi | 57.11 | 57.07 | 57.05 | 55.39 | 54.77 | 54.60 |
| LT debt / equityi | 236.07 | 230.75 | 226.13 | 218.23 | 212.87 | 204.53 |
| Interest coveragei | 0.37 | 0.68 | 0.82 | 0.96 | 0.94 | 1.00 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Consumables is the largest reported line at 49.10% of revenue, across 3 reported segments.
- Supplies and companion animals follows at 32.61%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Consumables49.10%
Supplies and companion animals32.61%
Services and other18.29%
Quote time 2026-10-08 09:57:20 · For reference only, not investment advice and not tailored to your situation.